Skip to main content
. 2021 Nov 1;15:1311. doi: 10.3332/ecancer.2021.1311

Table 2. Summary of cases with treatment details.

Case 1 Case 2 Case 3 Case 4
Reason to excise nipple-areola complex Nipple tethering Sub-areolar lump Involved medial margin on vertical scar therapeutic mammoplasty – adjacent to nipple Incidental cancer on duct excision for nipple discharge
Whole tumour size (in mm) 60 50 60 17 and 6
Further axillary treatment No further treatment arm of POSNOC trial Axillary Radiotherapy Nil Nil
Specimen weight (in gm) 145 82 170 therapeutic mammoplasty
52 central excision
8.5 total duct excision
35 central excision
Specimen dimensions (ML×AP×SI) mm 86×75×40 77×25×65 80×70×45
40×35×62
45×30×15
55×40×43
Surgical margins Clear Inferior margin focally involved with DCIS: re-excised – no further malignancy NA (No further malignancy seen on central excision) Clear
Closest peripheral margin 1 mm (superior) > 5 mm >5 mm (medial) 10 mm
Duration of surgery (in min) 140 110 120 110
Adjuvant chemotherapy Yes No. Oncotype RS 11 (NHS PREDICT 4% for third generation) Yes, following vertical scar therapeutic mammoplasty No
Adjuvant radiotherapy Yes (breast with boost) – POSNOC no axillary RT Yes (breast, axilla, SCF) Yes (breast with boost) Yes (breast)
Adjuvant endocrine therapy Yes (Anastrozole) Yes (Anastrozole) Yes (Tamoxifen). Declined Zoladex, aromatase inhibitor and bisphosphonate Yes (Tamoxifen)
Wound complication Nil Nil Nil Nil
Shoulder function recovery Complete Complete Complete Complete
Aesthetic outcome Very good Excellent Excellent (right bigger than left pre radiotherapy) Excellent

ML, medio-lateral; AP: antero-posterior; SI, supero-inferior; NA: not applicable; RS, recurrence score; RT, radiotherapy